Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Letrozole (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis
- 19 Apr 2012 Actual patient number is 31 as reported by ClinicalTrials.gov.
- 29 Sep 2009 Planned number of patients (30) added as reported by ClinicalTrials.gov.
- 05 Jul 2007 Status changed from in progress to completed.